Trials / Completed
CompletedNCT01718262
Study Measuring Total Plasma Ropivacaine Levels During Continuous Peripheral Nerve Catheter Infusion
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 49 (actual)
- Sponsor
- Defense and Veterans Center for Integrative Pain Management · Academic / Other
- Sex
- All
- Age
- 18 Years – 89 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to measure the blood levels of the medicine called ropivacaine (local anesthetic) used to manage pain. Ropivacaine is a widely used medication and is not the subject of this study, but the investigators are studying how much of the drug can be found in the patient's blood, known as the blood level, of this medicine. Too much ropivacaine in a patient's blood can lead to local anesthetic toxicity. Once the nerve catheter is removed, local anesthetic toxicity is no longer a potential problem. However, there is little data on what ropivacaine blood levels are after having the catheter in for a long period of time(up to one month).
Conditions
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2011-11-01
- Completion
- 2011-11-01
- First posted
- 2012-10-31
- Last updated
- 2019-08-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01718262. Inclusion in this directory is not an endorsement.